| 注册
首页|期刊导航|中国临床药理学杂志|他克莫司对慢性肾小球肾炎大鼠的保护作用

他克莫司对慢性肾小球肾炎大鼠的保护作用

王玮 王梦婕 华坚

中国临床药理学杂志2025,Vol.41Issue(6):834-839,6.
中国临床药理学杂志2025,Vol.41Issue(6):834-839,6.DOI:10.13699/j.cnki.1001-6821.2025.06.016

他克莫司对慢性肾小球肾炎大鼠的保护作用

Protective effects of tacrolimus on chronic glomerulonephritis in rats

王玮 1王梦婕 1华坚2

作者信息

  • 1. 青岛大学附属青岛市海慈医院/青岛市中医医院药剂科,山东青岛 266033
  • 2. 青岛市市立医院肾内科,山东青岛 266000
  • 折叠

摘要

Abstract

Objective To explore the mechanism of tacrolimus mediating the protective effect on chronic glomerulonephritis(CGN)rats through regulating the expression of microRNA-145-5p(miR-145-5p)and modulating the C-X-C motif chemokine ligand 16/Ras homolog family member A/Rho-associated coiled-coil-containing protein kinase(CXCL16/RhoA/ROCK)pathway.Methods SD rats were randomly divided into the control group(administered an equal volume of 0.9%NaCl),model group(CGN model+equal volume of 0.9%NaCl),experimental group(CGN model+3 mg·kg-1·d-1 tacrolimus)and combined group(experimental group+tail vein injection of 140 nmol·L-1 miR-145-5p antagomir).Enzyme-linked immunosorbent assay was used to measure 24-hour urinary protein(PRO),blood urea nitrogen(BUN),and serum creatinine(SCr)levels.Real-time quantitative polymerase chain reaction was used to detect the relative expression level of miR-145-5p in rat kidney tissue;Western blotting was used to determine protein expression levels.Results The 24-hour PRO levels in the control,model and experimental groups were(7.44±2.16),(85.29±17.35)and(49.81±9.52)mg,respectively;the BUN levels were(5.82±1.03),(9.65±1.78)and(6.97±1.14)mmol·L-1,respectively;the SCr levels were(46.31±7.69),(93.57±16.94)and(58.72±8.36)μmol·L-1,respectively.The relative expression levels of miR-145-5p in the control,model,experimental and combined groups were 1.00±0.14,0.56±0.07,0.83±0.12 and 0.68±0.09,respectively;the TNF-α levels were(116.42±14.53),(237.56±26.18),(164.79±18.35)and(205.12±21.64)pg·mL-1,respectively;the IL-1β levels were(15.76±1.84),(52.41±6.27),(21.35±2.92)and(43.63±4.58)pg·mL-1,respectively;the IL-6 levels were(26.28±3.47),(71.53±8.64),(38.92±5.06)and(59.78±6.21)pg·mL-1,respectively;the CXCL16 expression levels were 1.00±0.12,1.62±0.17,1.23±0.14 and 1.45±0.15,respectively.Statistical analysis revealed significant differences between the model group and the control group,between the experimental group and the model group,and between the combined group and the experimental group for these indicators(P<0.05,P<0.01,P<0.001).Conclusion Tacrolimus can upregulate miR-145-5p,activate the CXCL16/RhoA/ROCK pathway,reduce inflammatory factors,and improve kidney damage in CGN rats.

关键词

他克莫司/微小分子核糖核酸145-5p/CXC配体16/Rho相关蛋白激酶/慢性肾小球肾炎

Key words

tacrolimus/microRNA-145-5p/CXC ligand 16/Rho-associated protein kinase/chronic glomerulone-phritis

分类

医药卫生

引用本文复制引用

王玮,王梦婕,华坚..他克莫司对慢性肾小球肾炎大鼠的保护作用[J].中国临床药理学杂志,2025,41(6):834-839,6.

中国临床药理学杂志

OA北大核心

1001-6821

访问量0
|
下载量0
段落导航相关论文